DK396288A - Vandige oploesninger af doxorubicin, hydrochlorid - Google Patents

Vandige oploesninger af doxorubicin, hydrochlorid

Info

Publication number
DK396288A
DK396288A DK396288A DK396288A DK396288A DK 396288 A DK396288 A DK 396288A DK 396288 A DK396288 A DK 396288A DK 396288 A DK396288 A DK 396288A DK 396288 A DK396288 A DK 396288A
Authority
DK
Denmark
Prior art keywords
aqueous solutions
doxorubicin
hydrochloride
doxorubicin hcl
solutions
Prior art date
Application number
DK396288A
Other languages
English (en)
Other versions
DK396288D0 (da
Inventor
Murray Arthur Kaplan
Robert Kevin Perrone
Joseph Ballard Bogardus
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK396288D0 publication Critical patent/DK396288D0/da
Publication of DK396288A publication Critical patent/DK396288A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK396288A 1987-07-16 1988-07-15 Vandige oploesninger af doxorubicin, hydrochlorid DK396288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7419087A 1987-07-16 1987-07-16

Publications (2)

Publication Number Publication Date
DK396288D0 DK396288D0 (da) 1988-07-15
DK396288A true DK396288A (da) 1989-01-17

Family

ID=22118217

Family Applications (1)

Application Number Title Priority Date Filing Date
DK396288A DK396288A (da) 1987-07-16 1988-07-15 Vandige oploesninger af doxorubicin, hydrochlorid

Country Status (11)

Country Link
EP (1) EP0299527B1 (da)
JP (1) JPH0655668B2 (da)
KR (1) KR920004097B1 (da)
AT (1) ATE74759T1 (da)
AU (1) AU612379B2 (da)
DE (1) DE3870064D1 (da)
DK (1) DK396288A (da)
ES (1) ES2033379T3 (da)
FI (1) FI883338A (da)
GR (1) GR3004383T3 (da)
PT (1) PT88016B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
JP3236608B2 (ja) * 1990-10-04 2001-12-10 日本化薬株式会社 ブレオマイシン類の安定な水溶液
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
KR100327400B1 (ko) * 1998-04-07 2002-05-09 구자홍 음극선관용편향요크
RU2162699C1 (ru) * 2000-02-14 2001-02-10 Закрытое Акционерное Общество "Нита-Фарм" Водно-дисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов
JP2002037737A (ja) * 2001-08-02 2002-02-06 Nippon Kayaku Co Ltd ブレオマイシン類の安定な水溶液
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
CA2606390A1 (en) * 2005-05-11 2006-11-16 Sicor, Inc. Stable lyophilized anthracycline glycosides
WO2007075092A1 (en) * 2005-12-29 2007-07-05 Instytut Biochemii I Biofizyki New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs
PE20211202A1 (es) 2017-08-24 2021-07-05 Novo Nordisk As Composiciones de glp-1 y sus usos
TW202140063A (zh) 2020-02-18 2021-11-01 丹麥商諾佛 儂迪克股份有限公司 醫藥配方

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795492B (en) * 1978-10-20 1981-05-27 Lilly Co Eli Stable erythromycin solution
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
GR3004383T3 (da) 1993-03-31
DK396288D0 (da) 1988-07-15
DE3870064D1 (de) 1992-05-21
EP0299527A1 (en) 1989-01-18
AU1905388A (en) 1989-01-19
FI883338A (fi) 1989-01-17
KR890001571A (ko) 1989-03-27
PT88016A (pt) 1989-06-30
AU612379B2 (en) 1991-07-11
PT88016B (pt) 1995-03-01
JPH0655668B2 (ja) 1994-07-27
ATE74759T1 (de) 1992-05-15
JPH01117894A (ja) 1989-05-10
KR920004097B1 (ko) 1992-05-25
ES2033379T3 (es) 1993-03-16
FI883338A0 (fi) 1988-07-13
EP0299527B1 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
DK0948965T3 (da) Stabile medicinske præparater indeholdende 4,5-epoxymorphinanderivater
PT670162E (pt) Formulacoes farmaceuticas contendo raloxifeno um tensioactivo e um diluente soluvel em agua
DK396288A (da) Vandige oploesninger af doxorubicin, hydrochlorid
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
IT8123603A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ES2052646T3 (es) Solucion no acuosa de hidrocloruro de doxorubicina.
DK15282A (da) Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
NO894811D0 (no) Vandig doxorubicinloesning.
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
ATE87210T1 (de) Doxorubicin-loesungen.
DK208687A (da) Substituerede quinoxalinyloxy-phenoxypropionsyre-derivater, deres fremstilling og anvendelse som herbicide midler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment